These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Pyoderma gangrenosum in a patient with essential thrombocythemia. King KW; Murray A J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935 [TBL] [Abstract][Full Text] [Related]
44. Pyoderma gangrenosum in the genital area: successful treatment using adalimumab. Bardazzi F; Magnano M; Tengattini V; Loi C Eur J Dermatol; 2018 Apr; 28(2):263-264. PubMed ID: 29378677 [No Abstract] [Full Text] [Related]
45. Pyoderma gangrenosum. Ravi MD; Sanju N Indian Pediatr; 2000 Nov; 37(11):1277. PubMed ID: 11086316 [No Abstract] [Full Text] [Related]
46. Intralesional methotrexate as an adjuvant treatment for pyoderma gangrenosum: A case report. Del Puerto C; Navarrete-Dechent CP; Carrasco-Zuber JE; Vera-Kellet C Indian J Dermatol Venereol Leprol; 2017; 83(2):277. PubMed ID: 27451930 [No Abstract] [Full Text] [Related]
47. [An unusual case of pyoderma gangrenosum with necrotizing granulomatous dermatitis]. Meier F; Berner D; Scherwitz C; Rassner G; Metzler G J Dtsch Dermatol Ges; 2003 Apr; 1(4):302-5. PubMed ID: 16285486 [TBL] [Abstract][Full Text] [Related]
48. Nicotine: does it have a role in the treatment of skin disease? Ingram JR Postgrad Med J; 2009 Apr; 85(1002):196-201. PubMed ID: 19417169 [TBL] [Abstract][Full Text] [Related]
49. The skin and systemic disease. Stollery N Practitioner; 2013 Jun; 257(1762):32-3. PubMed ID: 23905287 [No Abstract] [Full Text] [Related]
50. Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness. Ariane M; Bouaziz JD; de Masson A; Jachiet M; Bagot M; Lepelletier C Dermatol Ther; 2019 Jan; 32(1):e12774. PubMed ID: 30341800 [TBL] [Abstract][Full Text] [Related]
51. Pyoderma gangrenosum as a cause of spontaneous vulvovaginal ulceration. Langeland T; Rokkones E Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1220-1. PubMed ID: 15548161 [No Abstract] [Full Text] [Related]
52. [Extensive ulcerations in children: The difficulty diagnosing pyoderma gangrenosum]. Ramli I; Rachadi H; Amarouch H; Rimani M; Senouci K; Benzekri L; Hassam B Arch Pediatr; 2015 Jul; 22(7):753-5. PubMed ID: 26047747 [TBL] [Abstract][Full Text] [Related]
53. Rapid resolution of pyoderma gangrenosum after treatment with intravenous cyclosporine. Turner RB; Emer JJ; Weill M; Winterfield L; Friedman S; Qureshi AA J Am Acad Dermatol; 2010 Sep; 63(3):e72-4. PubMed ID: 20708467 [No Abstract] [Full Text] [Related]
55. Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature. Langan SM; Powell FC Int J Dermatol; 2005 Aug; 44(8):623-9. PubMed ID: 16101860 [No Abstract] [Full Text] [Related]
56. High-dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum. Greb JE; Gottlieb AB; Goldminz AM Dermatol Ther; 2016 Nov; 29(6):482-483. PubMed ID: 27502191 [No Abstract] [Full Text] [Related]
58. Pyoderma gangrenosum in a renal transplant recipient: a case report. Al-Hwiesh AK Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):559-63. PubMed ID: 17186692 [TBL] [Abstract][Full Text] [Related]